
Predictive Oncology POAI
Quarterly report 2025-Q3
added 11-14-2025
Predictive Oncology P/E Ratio 2011-2025 | POAI
Annual P/E Ratio Predictive Oncology
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.655 | -0.732 | -0.0473 | -2.46 | -0.48 | -0.385 | -1.33 | -0.706 | -0.991 | -2.5 | -1.75 | -5.04 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.0473 | -5.04 | -1.42 |
P/E Ratio of other stocks in the Medical instruments industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Baxter International
BAX
|
-33.7 | $ 19.11 | -0.03 % | $ 9.75 B | ||
|
Becton, Dickinson and Company
BDX
|
33.5 | $ 196.22 | 0.02 % | $ 56.4 B | ||
|
Luminex Corporation
LMNX
|
83.5 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
-0.046 | - | -9.52 % | $ 20.6 M | ||
|
Ekso Bionics Holdings
EKSO
|
-0.854 | $ 5.41 | -1.09 % | $ 109 M | ||
|
Antares Pharma, Inc.
ATRS
|
12.9 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
166 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
-6.23 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
27.2 | - | -0.05 % | $ 10.3 B | ||
|
Varian Medical Systems, Inc.
VAR
|
37.5 | - | -0.02 % | $ 16.3 B | ||
|
Harvard Bioscience
HBIO
|
-55 | $ 0.72 | -1.19 % | $ 30.5 M | ||
|
Alcon
ALC
|
113 | $ 80.27 | 0.18 % | $ 40.4 B | ||
|
ICU Medical
ICUI
|
-31 | $ 147.49 | 0.34 % | $ 3.6 B | ||
|
AtriCure
ATRC
|
-42.7 | $ 40.87 | 0.79 % | $ 1.92 B | ||
|
Atrion Corporation
ATRI
|
32.9 | - | - | $ 810 M | ||
|
iRhythm Technologies
IRTC
|
-30.8 | $ 177.96 | 1.23 % | $ 5.55 B | ||
|
electroCore
ECOR
|
-0.00156 | $ 4.88 | 0.41 % | $ 26.9 K | ||
|
Isoray
ISR
|
-0.309 | - | 0.03 % | $ 108 M | ||
|
AngioDynamics
ANGO
|
-10.4 | $ 13.18 | 0.15 % | $ 538 M | ||
|
Repro Med Systems
KRMD
|
-7.04 | $ 6.43 | -0.85 % | $ 293 M | ||
|
The Cooper Companies
COO
|
43.5 | $ 82.17 | -0.49 % | $ 16.4 B | ||
|
LeMaitre Vascular
LMAT
|
47 | $ 84.02 | -0.38 % | $ 1.89 B | ||
|
Glaukos Corporation
GKOS
|
-32 | $ 116.0 | -0.63 % | $ 5.62 B | ||
|
Haemonetics Corporation
HAE
|
18.3 | $ 79.61 | -0.61 % | $ 4.01 B | ||
|
InfuSystem Holdings
INFU
|
8.11 K | $ 9.11 | 0.28 % | $ 188 M | ||
|
Masimo Corporation
MASI
|
-29.4 | $ 133.07 | -0.16 % | $ 7.09 B | ||
|
Merit Medical Systems
MMSI
|
49.4 | $ 87.39 | - | $ 5.09 B | ||
|
Intuitive Surgical
ISRG
|
87.5 | $ 578.42 | 0.22 % | $ 205 B | ||
|
OraSure Technologies
OSUR
|
-13.3 | $ 2.42 | -0.41 % | $ 180 M | ||
|
Microbot Medical
MBOT
|
-1.09 | $ 2.1 | -3.67 % | $ 21.4 M | ||
|
Milestone Scientific
MLSS
|
-14.7 | $ 0.29 | 1.24 % | $ 23.1 M | ||
|
Nephros
NEPH
|
-14.3 | $ 5.13 | -1.91 % | $ 53.3 M | ||
|
NeuroMetrix
NURO
|
-1.12 | - | 5.05 % | $ 9.02 M | ||
|
Envista Holdings Corporation
NVST
|
-3.29 | $ 21.91 | -0.41 % | $ 3.77 B | ||
|
STERIS plc
STE
|
39.3 | $ 255.52 | -0.03 % | $ 25.2 B | ||
|
Pro-Dex
PDEX
|
16.8 | $ 40.38 | -0.05 % | $ 133 M | ||
|
Pulse Biosciences
PLSE
|
-9.91 | $ 14.78 | -0.54 % | $ 710 M | ||
|
ResMed
RMD
|
45 | $ 243.56 | -0.35 % | $ 35.6 B | ||
|
Utah Medical Products
UTMD
|
57.7 | $ 56.29 | - | $ 204 M | ||
|
Repligen Corporation
RGEN
|
0.303 | $ 164.49 | -0.71 % | $ 9.17 M | ||
|
DENTSPLY SIRONA
XRAY
|
-3.85 | $ 11.07 | 0.05 % | $ 2.25 B | ||
|
BioLife Solutions
BLFS
|
-56.4 | $ 25.24 | -0.69 % | $ 1.16 B | ||
|
Stereotaxis
STXS
|
-10.4 | $ 2.44 | 0.41 % | $ 197 M | ||
|
STAAR Surgical Company
STAA
|
-41.2 | $ 23.5 | -0.55 % | $ 1.15 B | ||
|
Retractable Technologies
RVP
|
-1.76 | $ 0.82 | -0.06 % | $ 24.5 M | ||
|
Teleflex Incorporated
TFX
|
89.2 | $ 122.33 | 0.35 % | $ 5.73 B | ||
|
West Pharmaceutical Services
WST
|
31.3 | $ 276.19 | -0.17 % | $ 20.2 B |